Company Profile
Public information reviewedAgomab Therapeutics NV
AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies.
USNASDAQ: AGMB
Follow
More
- Evidence records
- 1
- Published leadership records
- 0
- Record reviewed
- Sep 26, 2026

